IPO DossierMAINBOARD · NSE BSE
LiveBriefCalendarCompareAllotmentGMP TruthWatchlist
All IPOs
MAINBOARD · NSE · LISTED · NSE BSE MAINBOARD

Sahajanand Medical Technologies

Sahajanand Medical Technologies Limited is a public limited company incorporated on Oct 18, 2001, engaged in the development and manufacturing of minimally invasive coronary stent systems, headquartered in Mumbai, Maharashtra.

PRICE BAND
₹327–₹344
LOT / MIN
43 sh · ₹14,792
ISSUE SIZE
₹475.5 Cr · 27.36% fresh
GMP (UNOFFICIAL)
₹40 (+11.6%)
EST LISTING
₹384
Open: 15 Oct 2026Close: 19 Oct 2026Listing: 23 Oct 2026● NSE synced 17 Nov, 4:26 am
READING THE FILING…

“Sahajanand Medical Technologies: momentum beats fundamentals — a trader's IPO, not an investor's.”

⚡ LISTING-GAIN TRADER · 10 DAYS
NEUTRAL
0.0
/10
LISTING SCORE
Neutral
  • ▸Decent demand 4.29x
  • ▸Anchors took 29.4% — confident
Action → Apply only if QIB crosses 5x by Day 2, else skip.
◆ LONG-TERM INVESTOR · 3 YEARS
AVOID
0.0
/10
COMPOUNDER SCORE
Avoid zone
  • ▸Revenue shrinking — avoid for long term
  • ▸Thin -1% margins — fragile
  • ▸Profit not converting to cash — biggest red flag
  • ▸2 forensic red flags in DRHP footnotes
Action → Avoid for portfolio — better compounders listed already.
DRHP FOOTNOTE RED FLAGS — READ BEFORE APPLYING
  • ⚠ The company is required to obtain, renew or maintain statutory and regulatory permits, licenses and approvals; any delay or inability could adversely affect its business, financial condition, cash flows and results of operations.
  • ⚠ The company is dependent on a limited number of suppliers (top 10 suppliers contributed over 60% of purchases in recent fiscal years) and a single supplier for certain components; supply disruptions could adversely affect its business, financial condition, cash flows and results of operations.

Educational only. Not investment advice. GMP is unofficial chatter, never a promise.

SHARE THIS DOSSIERXWhatsAppTelegram

Demand — who is actually bidding?

Live from NSE's official bid feed. QIB is smart money — if QIB sleeps past Day 2, listing pop usually dies.

QIB (institutions)6.09x
NII (HNI)8.56x
Retail (you)1.64x
Total4.29x
Anchor: 29.4% of issue pre-placed · Registrar: MUFG Intime India Pvt.Ltd. · Bankers: Motilal Oswal Investment Advisors Ltd., Avendus Capital Private Limited
GREY MARKET TAPE · UNOFFICIAL
₹40

Unofficial chatter, tracked daily — direction signal, never a promise.

HNI split — sNII (₹2–10L): 6.55x · bNII (>₹10L): 9.57x

Issue structure — where does money go?

27.36% fresh
  • ▸Offer for sale of 2.76 crore shares
  • Promoter 36.8% → 0% after IPO
⚠ Mostly OFS — you are buying the promoter out, not the future.

Deep financials — does profit become cash?

FYREVENUEPATMARGINROEROCED/ECFO
FY25₹1035.96 Cr₹25.15 Cr2.4%———₹0 Cr
FY26₹1218.73 Cr₹69.08 Cr5.7%———₹0 Cr
FY24₹908.59 Cr₹-7.35 Cr-0.8%———₹0 Cr
📈 3-yr revenue CAGR -6%
💰 PAT margin -1% · CFO/PAT 0.00x
⚖️ Peers → Molbio Diagnostics 84.65x · Manipal Health nullx

Valuation vs listed peers

COMPANYP/EP/BROE
Sahajanand Medical Technologies (IPO)——-0.8% margin
Rays of56.67——
Molbio Diagnostics84.65——
Manipal Health———

Read it as: peers show what the market already pays for this business model. IPO multiples land with the RHP parse.

Risk dossier

  1. 01The company is required to obtain, renew or maintain statutory and regulatory permits, licenses and approvals; any delay or inability could adversely affect its business, financial condition, cash flows and results of operations.
  2. 02The company is dependent on a limited number of suppliers (top 10 suppliers contributed over 60% of purchases in recent fiscal years) and a single supplier for certain components; supply disruptions could adversely affect its business, financial condition, cash flows and results of operations.

Street tape

Documents & filings

Primary sources — the same PDFs our dossier numbers come from.

Questions investors ask about Sahajanand Medical Technologies

Should I apply for the Sahajanand Medical Technologies IPO for listing gains?

Only if Day-2 QIB crosses 5x — otherwise the listing setup is weak.

Is Sahajanand Medical Technologies good for the long term?

Not yet — wait for cheaper re-entry or cleaner quarters.

What is the Sahajanand Medical Technologies IPO price band and lot size?

₹327–₹344, lot of 43 shares (min ₹14,792). Open 15 Oct 2026 to 19 Oct 2026.

How do I check Sahajanand Medical Technologies IPO allotment status?

On the MUFG Intime India Pvt.Ltd. portal: select Sahajanand Medical Technologies, enter PAN, application number, or DP/Client ID, solve the captcha. Results go live 6–10 PM on allotment evening (issue closed 19 Oct 2026). BSE's application-status page works as fallback.

When is the Sahajanand Medical Technologies listing date?

Tentatively 23 Oct 2026 (T+3 after close).

Who should apply?

  • • Listing trader → yes, momentum is real
  • • Long-term holder → wait for cheaper re-entry
  • • First-time investor → learn by watching, not betting

Listing-day playbook

  • • Opens +40%↑ → book half, keep rest at cost stop
  • • Opens flat ±5% → hold only if long-term score ≥7
  • • Opens discount → never average down Day 1

Allotment check

Nothing to check yet — basis finalises the evening after close (19 Oct 2026).How allotment day works → Registrar: MUFG Intime India Pvt.Ltd.